Ask AI
ProCE Banner Series

EngageTD: Workshop-Based Training in Tardive Dyskinesia Evaluation and Personalized Care

Join this 90-minute, AAPA/ANCC-certified, live virtual intensive workshop tailored specifically for nurse practitioners and physician associates who treat patients with dopamine receptor–blocking agents such as antipsychotics. Tardive dyskinesia, which can be associated with these agents, is an unrecognized burden for many patients but can be effectively managed when identified with recommended screening and assessment tools.

  AAPA
  | ANCC with Pharmacotherapy Credit
Who Should Attend

This educational activity is intended for nurse practitioners, nurses, physician associates, and others involved in the care of patients with tardive dyskinesia who may benefit from this education.

All Events

EngageTD: Workshop-Based Training in Tardive Dyskinesia Evaluation and Personalized Care

Upcoming Events

June

24

2026

6:30 PM - 8:00 PM Eastern Time (ET)

Virtual

Topics

  • Implement proactive risk-stratification and monitoring strategies to identify and counsel older adults or long-term antipsychotic-treated patients at heightened risk for TD
  • Apply validated screening tools and structured assessment protocols within routine clinical workflows to ensure timely detection, documentation, and follow-up of TD across diverse care settings
  • Evaluate the efficacy, safety, and tolerability profiles of FDA-approved VMAT2 inhibitors to individualize pharmacologic management of TD in older adults and special populations

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of learners in an effort to optimize treatment for patients with tardive dyskinesia.

Target Audience
This educational activity is intended for nurse practitioners, nurses, physician associates, and others involved in the care of patients with tardive dyskinesia who may benefit from this education.

Learning Objectives
Upon completion of this event, participants should be able to:

  • Implement proactive risk-stratification and monitoring strategies to identify and counsel older adults or long-term antipsychotic-treated patients at heightened risk for TD
  • Apply validated screening tools and structured assessment protocols within routine clinical workflows to ensure timely detection, documentation, and follow-up of TD across diverse care settings
  • Evaluate the efficacy, safety, and tolerability profiles of FDA-approved VMAT2 inhibitors to individualize pharmacologic management of TD in older adults and special populations

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.5 contact hours, including 1.5 hour of pharmacotherapy credits.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

IPCE Credit Designation

A logo for a credit companyAI-generated content may be incorrect.

This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Teva.

Teva

For customer support please click here.

Mailing Address:

 

Decera Clinical
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191